DJIA 16,912.11 -70.48 -0.42%
NASDAQ 4,442.70 -2.21 -0.05%
S&P 500 1,969.95 -8.96 -0.45%
market minute promo

Exelixis (NASDAQ: EXEL)

4.33 -0.07 (-1.59%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

EXEL $4.33 -1.59%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.40
Previous Close $4.40
Daily Range $4.16 - $4.44
52-Week Range $3.02 - $8.41
Market Cap $843.0M
P/E Ratio -2.97
Dividend (Yield) $0.00 (0.0%)
Volume 4,018,831
Average Daily Volume 5,552,580
Current FY EPS -$1.56

Sector

Healthcare

Industry

Drugs

Exelixis (EXEL) Description

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. Website: http://www.exelixis.com/

News & Commentary Rss Feed

Exelixis' Q4 Loss Widens as Investors Await Key Trial Data

Exelixis reports a wider fourth-quarter loss on higher R&D and SG&A expenses, but also points towards a number of key trial events in 2014.

Cramer's Lightning Round - Exelixis Has 9 Lives (7/28/14)

'Mad Money' Lightning Round: Don't Sell General Electric Just Yet

Exelixis (EXEL) Jumps: Stock Adds 11.4% in Session - Tale of the Tape

Exelixis (EXEL) In A Perilous Reversal

Exelixis (EXEL) Showing Signs Of A Dead Cat Bounce Today

Tuesday's ETF Movers: IYG, XBI

Exelixis (EXEL) Soars: Stock Adds 23% in Session - Tale of the Tape

Exelixis (EXEL) Is Today's Perilous Reversal Stock

Pre-Market Most Active for Jul 15, 2014 : JPM, BAC, LO, VOD, EXEL, ALU, GPRO, FB, KNDI, ORAN, AAPL,

Pre-Market Most Active for Jul 15, 2014 : JPM, BAC, LO, VOD, EXEL, ALU, GPRO, FB, KNDI, ORAN, AAPL, GS

Roche Presents Encouraging Data on Cobimetinib - Analyst Blog

See More EXEL News...

EXEL's Top Competitors

EXEL $4.33 (-1.59%)
Current stock: EXEL
TMO $123.54 (-0.68%)
Current stock: TMO
ILMN $166.73 (0.39%)
Current stock: ILMN
WAT $105.16 (-0.20%)
Current stock: WAT